Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study

BJU International

Volumn 119, Issue 5, 2017, Pages 767-775

  Gratzke, Christian ^a   Barber, Neil ^b   Speakman, Mark J ^c   Berges, Richard ^d   Wetterauer, Ulrich ^e   Greene, Damien ^f   Sievert, Karl Dietrich ^g   Chapple, Christopher R ^h   Patterson, Jacob M ^h   Fahrenkrug, Lasse ⁱ   Schoenthaler, Martin ^e   Sonksen, Jens ⁱ  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b FRIMLEY PARK HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c TAUNTON AND SOMERSET HOSPITAL   (United Kingdom)

^d PAN Klinik am Neumarkt   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

^f CITY HOSPITALS SUNDERLAND NHS FOUNDATION TRUST   (United Kingdom)

^g UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^h SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

ⁱ GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

UroBPH; BPH; LUTS; prostatic urethral lift; sexual function; UroLift

Indexed keywords

ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; EJACULATION; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; MALE SEXUAL HEALTH QUESTIONNAIRE FOR EJACULATORY DYSFUNCTION; MULTICENTER STUDY; PATIENT CARE; PROSPECTIVE STUDY; PROSTATE HYPERTROPHY; PROSTATE SURGERY; PROSTATIC URETHRAL LIFT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SEXUAL BEHAVIOR; SOCIAL STATUS; TISSUE PRESERVATION; TRANSURETHRAL RESECTION; URINE FLOW RATE; UROLOGICAL IMPLANT; CLINICAL TRIAL; COMPARATIVE STUDY; FOLLOW UP; MIDDLE AGED; PROSTATE; PROSTATIC HYPERPLASIA; TIME FACTOR; URETHRA;

EJACULATION; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC HYPERPLASIA; TIME FACTORS; TRANSURETHRAL RESECTION OF PROSTATE; URETHRA;

EID: 85007389455     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.13714     Document Type: Article

References (29)

1. Low G, Molzahn A, Schopflocher D. Attitudes to aging mediate the relationship between older people's subjective health and quality of life in 20 countries. Health Qual Life Outcomes 2013; 11: 146
2. Berry S, Coffey D, Walsh P, Ewing L. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474–9
3. Rosenberg M, Staskin D, Kaplan S, MacDiarmid S, Newman K, Ohl D. A practical guide to the evaluation of treatment of male lower urinary tract symptoms in the primary care setting. Int J Clin Pract 2007; 61: 1535–46
4. Laumann E, Paik A, Glasser D et al. A cross-national study of subjective sexual well-being among older women and men: findings from the global study of sexual attitudes and behaviors. Arch Sex Behav 2006; 35: 145–61
5. Rosen R, Altwein J, Boyle P et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 2003; 44: 637–49
6. Martin D, Mulhall J. Enlarging the scope of managing benign prostatic hyperplasia: addressing sexual function and quality of life. Int J Clin Pract 2005; 59: 579–90
7. Carbone D, Hodges S. Medical therapy for benign prostatic hyperplasia: sexual dysfunction and impact on quality of life. Int J Impot Res 2003; 15: 299–306
8. Haltbakk J, Hanestad B, Hunskaar S. How important are men's lower urinary tract symptoms (LUTS) and their impact on the quality of life (QOL)? Qual Life Res 2005; 14: 1733–41
9. Patel V, Sivaraman A, Coelho R et al. Pentafecta: a new concert for reporting outcomes of robot-assisted laparoscopic radical prostatectomy. Eur Urol 2011; 59: 702–7
10. Sonksen J, Barber N, Speakman M et al. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol 2015; 68: 643–52
11. Roehrborn C, Rukstalis D, Barkin J et al. Three year results of the prostatic urethral L.I.F.T. study. Can J Urol 2015; 22: 7772–82
12. Roehrborn C. Prostatic urethral lift: a unique minimally invasive surgical treatment of male lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urol Clin North Am 2016; 43: 357–69
13. Shore N, Freedman S, Gange S et al. Prospective multi-center study elucidating patient experience after prostatic urethral lift. Can J Urol 2014; 21: 7094–101
14. Cantwell A, Bogache W, Richardson S et al. Multicentre prospective crossover study of the ‘prostatic urethral lift’ for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. BJU Int 2014; 113: 615–22
15. Chin P, Boton D, Jack G et al. Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology 2012; 79: 5–11
16. Gravas S, Bach T, Bachmann A et al. Management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO). Eur Assoc Urol 2015; http://uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/.
17. Roehrborn C, McConnell J, Barry M et al. American urological association guideline: management of benign prostatic hyperplasia (BPH). Am Urol Assoc 2003.
18. Miano R, De Nunzio C, Asimakopoulos A, Germani S, Tubaro A. Treatment options for benign prostatic hyperplasia in older men. Med Sci Monit 2008; 14: RA94–102
19. Reich O, Gratzke C, Bachmann A et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 2008; 180: 246–9
20. McNicholas T, Woo H, Chin P et al. Minimally invasive prostatic urethral lift: surgical technique and multinational experience. Eur Urol 2013; 64: 292–9
21. Ware JE Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220–33
22. Viktrup L, Hayes R, Wang P, Shen W. Construct validation of patient global impression of severity (PGI-S) and improvement (PGI-I) questionnaires in the treatment of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. BMC Urol 2012; 12: 30
23. Hossack T, Woo H. Validation of a patient reported outcome questionnaire for assessing success of endoscopic prostatectomy. Prostate Int 2014; 2: 182–7
24. Sacco E, Bientinesi R, Marangi F et al. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study. BJU Int 2012; 110: e837–44
25. Gandek B, Ware JE, Aaronson NK et al. Cross-validation of item selection and scoring for the SF-12 health survey in nine countries: results from the IQOLA project. J Clin Epidemiol 1998; 51: 1171–8
26. Halme A, Fritel X, Benedetti A, Eng K, Tannenbaum C. Implications of the minimal clinically important difference for health-related quality-of-life outcomes: a comparison of sample size requirements for an incontinence treatment trial. Value Health 2015; 18: 292–8
27. Casanova N, Jackson R, Dunn R, Faerber G, Wei J. Incontinence-related outcomes following photoselective vaporization of. J Urol 2010; 183: e741
28. Jenkins C, Stanton B, Niemcryk S et al. A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol 1988; 41: 313–21
29. Strope S, Vetter J, Elliott S, Andriole G, Olsen M. Use of medical therapy and success of laser surgery and transurethral resection of the prostate for benign prostatic hyperplasia. Urology 2015; 86: 1115–22